Verily Life Sciences Stock / Medical DevicesFounded: 2015

Verily, founded in 2015, is a life sciences research organization under Alphabet Inc. The company aims to leverage advanced technology to understand health better and to develop tools for early diagnosis and more effective treatments. Targeting healthcare systems and research institutions, Verily is headquartered in South San Francisco, California.

Register To Buy and Sell Shares

For more details on financing and valuation for Verily Life Sciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Verily Life Sciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Verily Life Sciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Utpal Koppikar
Chief Financial Officer
Scott Burke
Chief Technology Officer
Preston Simons
Chief Information Officer
Laura Donnell JD
Chief Legal Officer & General Counsel
Alix Hart
Chief Marketing Officer
Kerrie Peraino
Chief People Officer
Vindell Washington MD
Chief Clinical Officer & Director, Health Equity Center of Excellence
Jessica Mega MD
Stephen Gillett
Chief Executive Officer
Amy Abernethy Ph.D
Chief Medical Officer & President, Product Development
Andrew Trister
Chief Scientific Officer
Lisa Greenbaum
Chief Commercial Officer
Andrew Conrad Ph.D

Frequently Asked Questions About Verily Life Sciences’ Stock

Can you buy Verily Life Sciences’ stock?
Verily Life Sciences is not publicly traded on NYSE or NASDAQ in the U.S. To buy Verily Life Sciences’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Verily Life Sciences’ stock?
Yes, you can sell stock of a private company like Verily Life Sciences. Forge can help you sell your Verily Life Sciences stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Verily Life Sciences’ stock price?
Verily Life Sciences is a privately held company and therefore does not have a public stock price. However, you may access Verily Life Sciences’ private market stock price with Forge Data.
What is Verily Life Sciences’ stock ticker symbol?
Verily Life Sciences does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Exclusive: Verily welcomes Atara Biotherapeutics veteran as new CFO
Verily, Alphabet’s life sciences outfit, has plucked a new CFO from the ranks of Atara Biotherapeutics, the company announced on Wednesday. Utpal Koppikar joins Verily after a nearly five-year stint as CFO and senior VP at Atara, though his résumé also boasts roles at Gilead and Amgen.
Updated on: May 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.